Skip to main content
Addgene

pfa6a mScarlet-TsCC(B)::KANMX
(Plasmid #176397)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 176397 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pfa6a::KAN
  • Total vector size (bp) 5817
  • Vector type
    Bacterial Expression, Yeast Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    mScarlet-TsCC(B)
  • Species
    S. cerevisiae (budding yeast)
  • Insert Size (bp)
    1641
  • Promoter none
  • Tag / Fusion Protein
    • mScarlet fused to TsCC(B) (C terminal on backbone)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site PacI (not destroyed)
  • 3′ cloning site AscI (not destroyed)
  • 5′ sequencing primer SP6
  • 3′ sequencing primer none
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Plasmid is used for cloning and integrating PCR products into yeast genome.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pfa6a mScarlet-TsCC(B)::KANMX was a gift from Matthew Good (Addgene plasmid # 176397 ; http://n2t.net/addgene:176397 ; RRID:Addgene_176397)
  • For your References section:

    Designer membraneless organelles sequester native factors for control of cell behavior. Garabedian MV, Wang W, Dabdoub JB, Tong M, Caldwell RM, Benman W, Schuster BS, Deiters A, Good MC. Nat Chem Biol. 2021 Sep;17(9):998-1007. doi: 10.1038/s41589-021-00840-4. Epub 2021 Aug 2. 10.1038/s41589-021-00840-4 PubMed 34341589